AAAAAA

   
Results: 1-7 |
Results: 7
A PHASE I II STUDY OF THE PROTEASE INHIBITOR INDINAVIR IN CHILDREN WITH HIV-INFECTION/
Authors: MUELLER BU SLEASMAN J NELSON RP SMITH S DEUTSCH PJ JU W STEINBERG SM BALIS FM JAROSINSKI PF BROUWERS P MISTRY G WINCHELL G ZWERSKI S SEI SZ WOOD LV ZEICHNER S PIZZO PA
Citation: Bu. Mueller et al., A PHASE I II STUDY OF THE PROTEASE INHIBITOR INDINAVIR IN CHILDREN WITH HIV-INFECTION/, Pediatrics (Evanston), 102(1), 1998, pp. 101-109
A PHASE I II STUDY OF THE PROTEASE INHIBITOR RITONAVIR IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION/
Authors: MUELLER BU NELSON RP SLEASMAN J ZUCKERMAN J HEATHCHIOZZI M STEINBERG SM BALIS FM BROUWERS P HSU A SAULIS R SEI S WOOD LV ZEICHNER S KATZ TTK HIGHAM C AKER D EDGERLY M JAROSINSKI P SERCHUCK L WHITCUP SM PIZZUTI D PIZZO PA
Citation: Bu. Mueller et al., A PHASE I II STUDY OF THE PROTEASE INHIBITOR RITONAVIR IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION/, Pediatrics, 101(3), 1998, pp. 335-343
GLYCOCALICIN LEVELS IN THE PLASMA OF HIV- AN INDICATOR OF PLATELET TURNOVER( PATIENTS )
Authors: WILLIAMS SB SANO M SMITH N HORNE M YARCHOAN R WYVILL K ZEICHNER S TAYLOR P KNUDSON T GRALNICK HR
Citation: Sb. Williams et al., GLYCOCALICIN LEVELS IN THE PLASMA OF HIV- AN INDICATOR OF PLATELET TURNOVER( PATIENTS ), The Journal of laboratory and clinical medicine, 132(4), 1998, pp. 303-307
NEUROENDOCRINE CARCINOMA IN 3 AIDS PATIENTS - ANOTHER AIDS-RELATED MALIGNANCY
Authors: LASH A LUBENSKY I SCHWARTZ A TAPPER M SCHOEM S ZEICHNER S JANKELEVICH S JAFFE E
Citation: A. Lash et al., NEUROENDOCRINE CARCINOMA IN 3 AIDS PATIENTS - ANOTHER AIDS-RELATED MALIGNANCY, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 66-66
A PILOT-STUDY OF RECOMBINANT IL-2 IN CHILDREN AND ADOLESCENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: WOOD LV WIGGINTON JM ZUCKERMAN J HIGHAM C LOY S BROUWERS P LANE HC TOWNLEY E JANKELEVICH S SERCHUK L SEI S ZEICHNER S
Citation: Lv. Wood et al., A PILOT-STUDY OF RECOMBINANT IL-2 IN CHILDREN AND ADOLESCENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Journal of allergy and clinical immunology, 99(1), 1997, pp. 433-433
LAMIVUDINE IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A PHASE I II STUDY/
Authors: LEWIS LL VENZON D CHURCH J FARLEY M WHEELER S KELLER A RUBIN M YUEN G MUELLER B SLOAS M WOOD L BALIS F SHEARER GM BROUWERS P GOLDSMITH J PIZZO PA ANDERSON B HIRSCHFELD S SEI S ZEICHNER S ROILIDES E CLERICI M WELLS M STOCKER V HIGHAM C TOWNLEY E WALSEK C ZWERSKI S HEILMAN N SELKINGUTMAN G WOLTERS P MOSS H JAROSINSKI P
Citation: Ll. Lewis et al., LAMIVUDINE IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A PHASE I II STUDY/, The Journal of infectious diseases, 174(1), 1996, pp. 16-25
SODIUM-BUTYRATE TREATMENT OF CELLS LATENTLY INFECTED WITH HIV-1 RESULTS IN THE EXPRESSION OF UNSPLICED VIRAL-RNA
Authors: LAUGHLIN MA ZEICHNER S KOLSON D ALWINE JC SESHAMMA T POMERANTZ RJ GONZALEZSCARANO E
Citation: Ma. Laughlin et al., SODIUM-BUTYRATE TREATMENT OF CELLS LATENTLY INFECTED WITH HIV-1 RESULTS IN THE EXPRESSION OF UNSPLICED VIRAL-RNA, Virology, 196(2), 1993, pp. 496-505
Risultati: 1-7 |